Profil
Daniel Wagner is currently Director at Biorez, Inc., SAMI Health, Inc., AlloMek Therapeutics LLC, and Tangen Biosciences, Inc., and Senior Managing Director at New Haven Pharmaceuticals, Inc. Former roles include Director at RemoteReality Corp., FMP Products, Inc., EpiEP, Inc., CMDBioscience, Inc., Innovatient Solutions, Inc., P2 Science, Inc., Synbody Biotechnology, Inc., and Azitra, Inc., Independent Director at IsoPlexis Corp.
from 2014 to 2023, Senior Managing Director at Connecticut Innovations, Inc. from 2018 to 2026, and Principal at CuraGen Corp.
Education includes undergraduate and MBA degrees from Quinnipiac University, and undergraduate studies at the University of Dayton.
Aktive Positionen von Daniel Wagner
| Unternehmen | Position | Beginn |
|---|---|---|
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops new prescription drug products | Corporate Officer/Principal | - |
Biorez, Inc.
Biorez, Inc. Medical SpecialtiesHealth Technology Operates as medical device company | Direktor/Vorstandsmitglied | - |
SAMI Health, Inc.
SAMI Health, Inc. Medical/Nursing ServicesHealth Services Provides healthcare information technology services | Direktor/Vorstandsmitglied | - |
Tangen Biosciences, Inc.
Tangen Biosciences, Inc. Medical SpecialtiesHealth Technology Develops innovative portable instruments and methods for use in molecular diagnostics | Direktor/Vorstandsmitglied | 01.12.2015 |
AlloMek Therapeutics LLC
AlloMek Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops therapeutics for catastrophic cardiomyopathy | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Daniel Wagner
| Unternehmen | Position | Ende |
|---|---|---|
Connecticut Innovations, Inc.
Connecticut Innovations, Inc. Investment ManagersFinance CI invests in companies located in the US, primarily in Connecticut. The firm targets companies operating in the fields of Greentech, Consumer, Healthcare, Venture Funds, Technology. It provides debt and equity financing for seed and early stage capital requirements with an investment size up to $500,000. | Private Equity Investor | 01.07.2026 |
| ISOPLEXIS CORPORATION | Direktor/Vorstandsmitglied | 21.03.2023 |
| AZITRA, INC. | Direktor/Vorstandsmitglied | - |
EpiEP, Inc.
EpiEP, Inc. Medical SpecialtiesHealth Technology Develops heart-related medical devices | Direktor/Vorstandsmitglied | - |
| ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Daniel Wagner
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 18 |
|---|---|
Connecticut Innovations, Inc.
Connecticut Innovations, Inc. Investment ManagersFinance CI invests in companies located in the US, primarily in Connecticut. The firm targets companies operating in the fields of Greentech, Consumer, Healthcare, Venture Funds, Technology. It provides debt and equity financing for seed and early stage capital requirements with an investment size up to $500,000. | Finance |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
RemoteReality Corp.
RemoteReality Corp. Electronics/Appliance StoresRetail Trade Designs and manufactures ultra wide-angle computational cameras and video systems | Retail Trade |
Biorez, Inc.
Biorez, Inc. Medical SpecialtiesHealth Technology Operates as medical device company | Health Technology |
FMP Products, Inc.
FMP Products, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and sells laboratory automation equipment to pharmaceutical companies | Health Technology |
EpiEP, Inc.
EpiEP, Inc. Medical SpecialtiesHealth Technology Develops heart-related medical devices | Health Technology |
CMDBioscience, Inc.
CMDBioscience, Inc. Pharmaceuticals: GenericHealth Technology Design and develops computer aided peptide drug discovery solutions | Health Technology |
Innovatient Solutions, Inc.
Innovatient Solutions, Inc. Medical/Nursing ServicesHealth Services Provides patient engagement health care solutions | Health Services |
P2 Science, Inc.
P2 Science, Inc. Chemicals: Major DiversifiedProcess Industries Manufactures chemicals for liquid polymers and cosmetics | Process Industries |
SAMI Health, Inc.
SAMI Health, Inc. Medical/Nursing ServicesHealth Services Provides healthcare information technology services | Health Services |
Synbody Biotechnology, Inc.
Synbody Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates a revolutionary platform for the discovery and development of novel & attractive molecules | Health Technology |
IsoPlexis Corp.
IsoPlexis Corp. Medical SpecialtiesHealth Technology Develops single cell multiplexing immunoassay systems | Health Technology |
Quinnipiac University
Quinnipiac University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Dayton
University of Dayton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops new prescription drug products | Health Technology |
AlloMek Therapeutics LLC
AlloMek Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops therapeutics for catastrophic cardiomyopathy | Health Technology |
Tangen Biosciences, Inc.
Tangen Biosciences, Inc. Medical SpecialtiesHealth Technology Develops innovative portable instruments and methods for use in molecular diagnostics | Health Technology |
Azitra, Inc.
Azitra, Inc. Pharmaceuticals: MajorHealth Technology Operates as an clinical biopharmaceutical company that develops and commercializes therapies for precision dermatology | Health Technology |
















